Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas

Trial Profile

A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas

Phase of Trial: Phase I

Latest Information Update: 17 Sep 2014

At a glance

  • Drugs Dronabinol (Primary)
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 21 Feb 2012 Planned end date changed from 1 Dec 2009 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 21 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top